Team
Christine Johnson
Co-Founder & Chief Executive Officer
With a background in bringing disruptive technologies to new markets, Christine bridges the gap between research and commercialization. By understanding the unique needs of both scientists and customers, she works to create a seamless transition from groundbreaking research to practical applications. This ensures that the potential of quantum technology is not only realized in the lab but also translated into solutions that serve our customers and create tangible positive outcomes.
Marko Djukic
Co-Founder & Chief Technology Officer
Marko has decades of technology experience, specializing in financial services. After a successful exit as Founder and CEO of financial services cloud business Hentsu, Marko went on to achieve a MicroMasters in Quantum Technology at Purdue. At Ingenii, Marko is responsible for the technical development of our quantum computing strategies.
Chief Science Officer
Laia Domingo, PhD
Laia is an experienced data and quantum algorithm scientist. She has a Masters in Data Science and a PhD from ICMAT in Artificial Intelligence and Mathematics for Quantum Physics. At Ingenii, she spearheads everything quantum from research to product design.
Head of Data Engineering
Greg Atkins, MSc
Greg has applied his mathematical and engineering background to deploy data science solutions to various enterprises over the last decade. With a Masters in Computer Aided Engineering, Greg is responsible for Ingenii’s data engineering and the integration of quantum computing into data analytics.
Chief Marketing Officer
Annie Ratner
Annie has proven track record of steering early-stage startups towards success, bringing a unique blend of strategic vision and hands-on execution to drive innovative and effective marketing strategies. At Ingenii, Annie leads marketing and community development strategies to ensure customer and market feedback are at the core of everything we build
Advisors
Dr. Sabre Kais, PhD
Senior Advisor: Quantum Algo Development
After completing a BSc, MSc and Ph.D degree at Hebrew University of Jerusalem, Dr. Kais went on to become a research associate at Harvard University, Department of Chemistry. He later joined Purdue University as Assistant Professor of Theoretical Chemistry.
Currently, he is a distinguished Professor of Chemical Physics, a Professor of Computer Science, a Professor of Physics, and Professor of Electrical and Computer Engineering at Purdue University.
Dr. Kais has over 260 publications in peer-reviewed journals. The research in his group is mainly devoted to finite size scaling and quantum phase transitions, dimensional scaling, quantum information and quantum computing. He is also the Center Director for the NSF Center of Quantum Technologies.
Scott Roman
Investor & Senior Advisor
Scott is Founder and Managing Partner of White Shark Management, a seed stage investment firm focused on new normals, Scott serves as strategic advisor to multiple technology companies in the enterprise software, advanced manufacturing, and consumer technology spaces.
Prior to founding White Shark, Scott was a member of the Technology Services investment banking group at Raymond James where he focused on mergers and acquisitions, equity and debt financings, and strategic advisory. He went on to Century Equity Partners where he served in numerous board-level roles, provided financial, operational, and strategic support to select portfolio companies, and evaluated investment opportunities across the financial and healthcare sectors.
Dr. Gaurav Chopra
QML for Drug Discovery
Gaurav is an Associate Professor of Chemistry and Computer Science at Purdue University and the Director of the Merck-Purdue Center - Merck sponsored Center funding research projects across Purdue University. Gaurav is also a core member of Regenstrief Center for Healthcare Engineering, Purdue Institutes for Cancer Research, Drug Discovery, Immunology and Integrative Neuroscience. Gaurav’s research includes neuroimmunology, artificial intelligence, targeted drugs, cancer immunotherapy and digital healthcare.
Gaurav is an AnaytiXIN (Analytics Indiana) Fellow in Life Sciences and a Scialog Fellow for Automating Chemical Laboratories, an initiative by Beckman Foundation and the Research Corporation for Science Advancement.
Elvira Shishenina
Quantum Solutions
Elvira is the Quantum Computing lead at BMW Group and holds positions as the President and Co-Founder of numerous quantum research groups like Le Lab Quantique.
As a leader in the French quantum ecosystem, an established mathematician, and experienced business leader, we are thrilled to have Elvira as our business liaison and advisor to help maximize the benefits of our participation in the Duality program and ensure we're building industry-relevant solutions.
Dr. Alexander Stevens
Alex is an expert technologist and informaticist at Memorial Sloan Kettering Cancer Center (MSKCC), one of the world's leading cancer centers.
Alex is passionate about ethical artificial intelligence (AI) and machine learning (ML) and has developed a new theory of trust and acceptance of AI in healthcare called TrAAIT, and a framework for implementing fair, safe, trustworthy, and ethical AI called FASTER.
QNNs for Cancer Research
Partners
Cloud Partner
Cloud Partner
Cloud Partner
Data Partner
Our Chief Science Officer, Laia Domingo Colomer, PhD, is collaborating with Purdue Data Mine on improving the speed and accuracy of cancer precision therapy. We plan to do this using quantum computing, not only considering molecule and protein interactions on a proteomic level, but also the patient data, resulting in a complex quantum machine learning (QML) model which would not be possible with classical methods and resources.
Institutional Partner
Institutional Partner
Ingenii is one of four startups in Duality Accelerator Cohort 3. Duality is led by the Polsky Center for Entrepreneurship and Innovation at the University of Chicago and the Chicago Quantum Exchange (CQE), along with founding partners, the University of Illinois Urbana-Champaign, Argonne National Laboratory, and P33. Duality is a first-of-its-kind accelerator aimed at supporting next-generation startups focused on quantum science and technology. The 12-month program provides world-class business and entrepreneurship training from its partner institutions and the University of Chicago Booth School of Business. Read the official announcement here.